Tag: active surveillance

The strategy of using active surveillance (AS) is increasingly recommended to low-risk prostate cancer (PCa) patients as a way to avoid or delay overtreatment. This is a new way of thinking; before the New Millennium, PCa was assumed to be multi-focal and most men with more than 10 years of life expectancy were hurried into surgery or radiation. Today’s terminology includes words that might have been meaningless a decade ago, e.g. indolent cancer, very low risk disease, and focal disease are all consistent with the growing movement toward AS. keep reading

Active surveillance can be a nerve-wracking experience for many men, with constant monitoring adding to the stress. Focal therapy offers a precise, low-impact alternative that targets the cancer while sparing you from the side effects of aggressive treatments. Discover how it can bring peace of mind without overtreatment. keep reading

Could a man’s sexual behavior impact his prostate cancer risk? Recent research suggests a connection between the frequency of ejaculation, the number of sexual partners, and prostate cancer risk. Explore the latest findings and discover how your lifestyle choices might influence your health. keep reading

When you think of turning points in history, what comes to mind? The fall of the Berlin Wall? Einstein’s theory of relativity? The women suffragettes? Toppled regimes, scientific discoveries, and allowing women to vote dramatically alter the course of human events. Sometimes, however, the wheel of change is not obvious. You might be in the keep reading

Did you ever watch a murder mystery in which all the clues appear to point to an easy solution—but there’s a late breaking twist when the killer turns out to have “hiding in plain sight” all along? Here’s a similar situation: all the usual clinical factors seem to indicate that a prostate cancer patient has keep reading

I came across a journal article by a Brazilian urologic specialist, Dr. Stênio Cássio Zequi of the Camargo Cancer Center in São Paulo, Brazil. He asks if focal therapy will be the next step in prostate cancer management. Before expressing his opinion, he writes what amounts to a “snapshot” of the current state of prostate cancer treatment... keep reading

Has this ever happened to you? You don’t feel well or you have a weird symptom and you make an appointment with your doctor. After discussion and maybe a test or two, your doc gives you a diagnosis. You have a condition that is not life threatening at the moment (such as low-risk prostate cancer) keep reading

As promised, the analyzed results of the MEAL study (2011-15) described below were finally published by JAMA in January, 2020.iIf the authors were hoping to show that increasing vegetable intake could slow progression of prostate cancer (PCa) among patients on Active Surveillance, they must have been... keep reading

More and more prostate cancer patients and their doctors are turning to Active Surveillance (AS). Data shows that for carefully chosen low risk patients, AS is a way to hold off on treatment like surgery or radiation without significantly increasing the chances of death from prostate cancer... keep reading

Previously, we posted a recommended caution that men of African American descent discuss possible risks of going on Active Surveillance (AS) even when early clinical factors suggested they qualify for AS. Then, the authors of a 2018 paper noted that the observational studies encouraging more use of AS were largely composed of White men, raising the question of whether positive results of those studies should be applied to Black men. After reviewing studies that focused on Black men, they concluded... keep reading